We employed the ATN classification system based on the CSF levels of amyloid-β (1–42) (A), phosphorylated-Tau (T), and total-tau (N) [20], which is proposed by the 2018 National Institute on Aging-Alzheimer’s Association (NIA-AA) Research Framework [21]. Here, MAPT is linked to oculocutaneous albinism type 1.